In addition, the presence of Bmi-1 autoantibodies in sera from patients with ESCC may have clinical utility in esophageal cancer screening, diagnosis and prediction of lymph node metastasis. This evidence concerns the gene BMI1 and esophageal squamous cell carcinoma.